thalidomide has been researched along with Amentia in 3 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Jolobe, OM | 1 |
Kübra Elçioğlu, H | 1 |
Kabasakal, L | 1 |
Tufan, F | 1 |
Elçioğlu, ÖH | 1 |
Solakoglu, S | 1 |
Kotil, T | 1 |
Karan, MA | 1 |
Morgan, AE | 1 |
Smith, WK | 1 |
Levenson, JL | 1 |
3 other studies available for thalidomide and Amentia
Article | Year |
---|---|
Dementia and multiple myeloma.
Topics: Aged; Back Pain; Blood Viscosity; Dementia; Dexamethasone; Female; Glucocorticoids; Headache; Humans | 2017 |
Effects of systemic Thalidomide and intracerebroventricular Etanercept and Infliximab administration in a Streptozotocin induced dementia model in rats.
Topics: Animals; Antibodies, Monoclonal; Dementia; Disease Models, Animal; Etanercept; Immunoglobulin G; Inf | 2015 |
Reversible dementia due to thalidomide therapy for multiple myeloma.
Topics: Aged; Angiogenesis Inhibitors; Dementia; Humans; Male; Multiple Myeloma; Thalidomide; Tremor | 2003 |